{"title":"脂钙素-2在中风中的作用。","authors":"Wen-Hai Chou, Guona Wang, Varun Kumar, Yi-Chinn Weng","doi":"10.17140/NOJ-2-109","DOIUrl":null,"url":null,"abstract":"<p><p>Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Li-pocalin-2 (LCN2) is an acute phase protein mediating neuroinflammation after ischemic and hemorrhagic strokes. This review is an attempt to summarize some LCN2-related research findings and discuss its role in stroke.</p>","PeriodicalId":74268,"journal":{"name":"Neuro : open journal","volume":"2 1","pages":"38-41"},"PeriodicalIF":0.0000,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287915/pdf/","citationCount":"9","resultStr":"{\"title\":\"Lipocalin-2 in Stroke.\",\"authors\":\"Wen-Hai Chou, Guona Wang, Varun Kumar, Yi-Chinn Weng\",\"doi\":\"10.17140/NOJ-2-109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Li-pocalin-2 (LCN2) is an acute phase protein mediating neuroinflammation after ischemic and hemorrhagic strokes. This review is an attempt to summarize some LCN2-related research findings and discuss its role in stroke.</p>\",\"PeriodicalId\":74268,\"journal\":{\"name\":\"Neuro : open journal\",\"volume\":\"2 1\",\"pages\":\"38-41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287915/pdf/\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuro : open journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17140/NOJ-2-109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro : open journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17140/NOJ-2-109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Li-pocalin-2 (LCN2) is an acute phase protein mediating neuroinflammation after ischemic and hemorrhagic strokes. This review is an attempt to summarize some LCN2-related research findings and discuss its role in stroke.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
